On ECHEMI

Johnson Matthey Pharmaceutical Materials

United States
Favorite Supplier
 301 people visit

Company Profile

Johnson Matthey Pharmaceutical Materials, based in West Deptford, New Jersey, USA, is a leading manufacturer of active pharmaceutical ingredients.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:2:1), (6aR)-

4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:2:1),(6aR)-;4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:1),(R)-;4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-,hydrochloride,hydrate (2:1),(6aR)-;Apomorphine hydrochloride hemihydrate;(R)-(-)-Apomorphine hydrochloride hemihydrate
41372-20-7 Inquiry

Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1)

Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-,chloride (1:1);Ammonium,ethyl(m-hydroxyphenyl)dimethyl-,chloride;Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-,chloride;Ethyl(m-hydroxyphenyl)dimethylammonium chloride;Dimethylethyl(3-hydroxyphenyl)ammonium chloride;Edrophonium chloride;Tensilon chloride;Tensilon;Ethyl(3-hydroxyphenyl)dimethylammonium chloride;Antirex;Reversol;Enlon;Edrophone chloride
116-38-1 Inquiry

Bimatoprost

5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-,(5Z)-;5-Heptenamide,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-,[1R-[1α(Z),2β(1E,3S*),3α,5α]]-;5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-,(5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide;Bimatoprost;AGN 192024;Lumigan;Prostamide;Latisse;17-Phenyltrinor-PGF2α ethylamide;267244-98-4
155206-00-1 Inquiry

Carboplatin

PARAPLATIN;1,1-cyclobutanedicarboxylatediammineplatinum(ii);1-cyclobutanedicarboxylato(2-)-o,o’)-diammine((sp-4-2)-platinu;1-cyclobutanedicarboxylato)diammine-(cis-platinum(ii;DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II);CARBOPLATIN;CARBOPLATINUM;CIS-DIAMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM
41575-94-4 Inquiry

Carmustin

Urea,N,N′-bis(2-chloroethyl)-N-nitroso-;Urea,1,3-bis(2-chloroethyl)-1-nitroso-;N,N′-Bis(2-chloroethyl)-N-nitrosourea;BCNU;1,3-Bis(2-chlorethyl)-1-nitrosourea;Carmustine;1,3-Bis(β-chloroethyl)-1-nitrosourea;NSC 409962;Carmustin;1,3-Bis(2-chloroethyl)-1-nitrosourea;BiCNU;Gliadel;Becenun;SK 27702;SRI 1720;Nitrumon;FDA 0345;Carmubris;DTI 015;Gliadel Wafer;1,3-Bis(2-chloroethyl)nitrosourea;Becenum;1159711-15-5;1191292-23-5
154-93-8 Inquiry

Cisplatin

Platinum,diamminedichloro-,(SP-4-2)-;Platinum,diamminedichloro-,cis-;(SP-4-2)-Diamminedichloroplatinum;cis-Diamminedichloroplatinum;cis-Dichlorodiamineplatinum(II);cis-Platinum(II) diaminodichloride;cis-Platinum(II) diamminedichloride;cis-Dichlorodiammineplatinum;cis-Platinous diaminodichloride;cis-Platinum diaminodichloride;cis-Platinumdiammine dichloride;cis-Platinumdiamine dichloride;cis-Diaminodichloroplatinum(II);NSC 119875;Cisplatin;cis-Platinum II;Platinol;Neoplatin;cis-Platine;Biocisplatinum;cis-DDP;cis-Diamminedichloroplatinum(II);Platidiam;cis-Platinum;Cisplatinum;CPDD;cis-Platin;cis-Dichlorodiammineplatinum(II);TR 170;CDDP;DDP;CPPD;cis-Diaminedichloroplatinum(II);Cisplatyl;Briplatin;DDP (antitumor agent);Abiplatin;SPI 077;CACP;Lederplatin;Platosin;Platamine;Platiblastin;Platistin;Platinoxan;CPDC;Cismaplat;Citoplatino;Rand;Platinex;Platinol AQ;SPI 077 (complex);SPI 077B103;Cisplatino;Lipoplatin;Randa;Fauldiscipla;IA-call;CP Ethypharm;LiPlaCis;Cisplatine Mylan;Kemoplat;Citoplax;Maruko;cis-Diaminedichloridoplatinum(II);cis-Diammineplatinum(II);96081-74-2;936542-99-3
15663-27-1 Inquiry

Galanthamine hydrobromide

6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide (1:1),(4aS,6R,8aS)-;Galanthamine,hydrobromide;6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide,(4aS,6R,8aS)-;Galantamine hydrobromide;Nivalin;Nivaline;Galanthamine hydrogen bromide;Nivaline (pharmaceutical);(-)-Galanthamine hydrobromide;Reminyl;Jilkon hydrobromide;Lycoremine hydrobromide;(-)-Galantamine hydrobromide;Razadyne;Tamilin
1953-04-4 Inquiry

Gold, [1-(thio-kS)-b-D-glucopyranose2,3,4,6-tetraacetato](triethylphosphine)-

Gold,[1-(thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)-;Gold,(1-thio-β-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-;Gold,(1-thio-β-D-glucopyranosato)(triethylphosphine)-,2,3,4,6-tetraacetate;β-D-Glucopyranose,1-thio-,2,3,4,6-tetraacetate,gold complex;[1-(Thio-κS)-β-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold;[(Tetra-O-acetyl-β-D-glucopyranosyl)thio](triethylphosphine)gold;SKF 39162D;Auranofin;Ridaura;SKF 39162;Crisofin;Crisinor;Aktil;Ridauran;NSC 321521;Gold Salt
34031-32-8 Inquiry

Oxaliplatin

Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;Platinum,(1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-,[SP-4-2-(1R-trans)]-;Platinum,[(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;1,2-Cyclohexanediamine,platinum complex,(1R-trans)-;(SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum;NSC 266046;Oxalatoplatinum;Oxalatoplatin;l-OHP;Oxaliplatin;RP 54780;Platinum,(1,2-cyclohexanediamine-κN,κN′)[ethanedioato(2-)-κO1,κO2]-,[SP-4-2-(1R-trans)]-;Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II);Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II);Eloxatin;Dacplat;trans-L-Diaminocyclohexane oxalatoplatinum;Elplat;Lipoxal
61825-94-3 Inquiry

Platinum, bis(acetato-kO)amminedichloro(cyclohexanamine)-,(OC-6-43)- (9CI)

Platinum,bis(acetato-κO)amminedichloro(cyclohexanamine)-,(OC-6-43)-;Platinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43)-;Cyclohexanamine,platinum complex;JM 216;Satraplatin;BMY 45594;POplat;BMS 182751;367265-85-8
129580-63-8 Inquiry

Platinum,amminedichloro(2-methylpyridine)-, (SP-4-3)-

Platinum,amminedichloro(2-methylpyridine)-,(SP-4-3)-;(SP-4-3)-Amminedichloro(2-methylpyridine)platinum;AMD 473;ZD 0473;Picoplatin;NX 473
181630-15-9 Inquiry

Prosta-5,13-dien-1-oicacid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E,15S)-

Prosta-5,13-dien-1-oic acid,11,15-dihydroxy-9-oxo-,(5Z,11α,13E,15S)-;5-Heptenoic acid,7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;5-Heptenoic acid,7-[3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-;(5Z,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid;PGE2;Prostaglandin E2;U 12062;11α,15α-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid;(15S)-Prostaglandin E2;(-)-Prostaglandin E2;11α,15α-Dihydroxy-9-ketoprosta-5,13-dienoic acid;Dinoprostone;Prostin E2;Prepidil;l-Prostaglandin E2;l-PGE2;Minprostin E2;Prostenon;Prostenone;Cervidil;Prostin;Prostin (prostaglandin);Glandin;Prostarmon E;Cerviprost;Propess;Minprositin E2;Enzaprost E;NSC 165560;NSC 196514;Primiprost;Cerviprime;11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11α,13E,15S);5: PN: US20150065431 SEQID: 5 claimed sequence;7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentyl]-5-heptenoic acid
363-24-6 Inquiry

Prostaglandin E1

Prost-13-en-1-oic acid,11,15-dihydroxy-9-oxo-,(11α,13E,15S)-;Cyclopentaneheptanoic acid,3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-,(-)-;Cyclopentaneheptanoic acid,3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-;(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid;PGE1;Prostaglandin E1;11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid;(-)-Prostaglandin E1;l-Prostaglandin E1;11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid;Alprostadil;U 10136;Prostandin;l-PGE1;Prostandin 500;Caverject;Alprox TD;Palux;ONO 1608;Lipoprost;Topiglan;SEPA-PGE1;SEPA-alprostadil;SEPA-prostaglandin E1;Minprog;Prostivas;Prostin VR Pediatric;Liple;NSC 165559;Caveject;Vasaprostan;Liprostin;Eglandin;Lipo PGE1;Alprostan;50-83-9;22299-37-2;50865-30-0
745-65-3 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.